BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2000
View Archived Issues
Meditech and Immune Network sign license option
Read More
Vion licenses potential HBV/HIV therapy to Achillion
Read More
IND filing in sight for new oral contraceptive
Read More
p38 MAPK inhibitor assessed in rat adjuvant-induced arthritis
Read More
Scios reviews 1999 developments
Read More
OxiGene highlights promising CA4P developments from Q4 and full year 1999
Read More
Generex initiates oral insulin trials in England
Read More
ID Biomedical's GAS vaccine well tolerated in early clinical testing
Read More
PPL Therapeutics' transgenic AAT shows promising results in phase II
Read More
Pharmacia & Upjohn in discussions with FDA regarding Vestra NDA
Read More
Major European introduction for Merck's COX-2 inhibitor
Read More
Microbiotix and BioChem Pharma to develop novel antibiotic agents
Read More
Miacalcin nasal spray receives Canadian approval as treatment for osteoporosis
Read More
Metabasis Therapeutics extends diabetes collaboration with Sankyo
Read More
Sulfonamide-based inhibitors of TNF-alpha production synthesized at Shionogi
Read More
New immunosuppressive agents derived from LK6-A
Read More
AHP prepares new rapamycin derivatives
Read More
SCRAS presents new class of NOS inhibitors and antioxidants
Read More
ORL1 antagonist J-113397 also being explored for cognition enhancement
Read More
Next-generation HBOCs in preclinical development at Hemosol
Read More
FDA issues approvable letter for Visudyne
Read More
UroGen cleared to begin phase I human clinical trial of gene therapy for hemophilia A
Read More
Clearance to begin clinical trial of novel acne treatment sought by Praxis
Read More
Preclinical studies support potential new indication for tamsulosin
Read More
FDA approves Actimmune for treatment of osteopetrosis
Read More
Novel Warner-Lambert compounds act as inhibitors of Lp(a) production
Read More
Components of naturally occurring antimicrobial complex isolated at Schering-Plough
Read More
Focal cerebral ischemic injury in rats improved by broad-spectrum ion channel blocker
Read More